BellaSeno's New Clinical Advisory Board to Drive Innovations
In an exciting development for the field of reconstructive surgery, BellaSeno GmbH has established a Clinical Advisory Board to enhance the clinical development of their cutting-edge resorbable breast implants. This board is made up of seven highly esteemed experts in clinical breast reconstruction and plastic surgery, each bringing a wealth of knowledge and significant contributions to the field.
Mohit Chhaya, the CEO of BellaSeno, expressed excitement about the formation of the board, stating, "We are delighted to have established a Clinical Advisory Board comprised of so many high-profile plastic surgeons and clinicians with outstanding experience in all relevant breast surgery procedures." He went on to highlight that the board members are not only board-certified plastic surgeons but also recognized leaders who have made major advances in aesthetic and reconstructive surgery through their clinical research efforts.
Meet the Experts of BellaSeno’s Advisory Board
The expertise of the Clinical Advisory Board members is truly remarkable. Here’s an overview of some prominent figures:
Dr. William P. Adams, Jr
Dr. William Adams is a board-certified plastic surgeon and Associate Professor at UT Southwestern Medical Center. He is known worldwide for his expertise in breast implant safety and serves as a trusted advisor to regulatory agencies like the FDA. Dr. Adams’s extensive work in breast augmentation, reconstruction, and body contouring connects clinical excellence with meaningful regulatory insights.
Dr. Patricia McGuire
Leading the charge in breast surgery and body contouring, Dr. Patricia McGuire is the president of the Aesthetic Society’s education and research foundation. Her influential role on implant safety task forces and editorial boards, along with her research advancing the understanding of breast implant illness and surgical outcomes, underscores her commitment to patient education and transparency.
Dr. Bob Basu
Dr. Bob Basu, MD, MBA, MPH, holds the position of incoming President of the American Society of Plastic Surgeons. His independent group practice, Basu Aesthetics + Plastic Surgery, focuses on breast enhancement and complex revision surgeries. Dr. Basu is recognized for shaping national standards and advocating for safety and innovation in aesthetic medicine.
Prof. Anand Deva
The Head of Cosmetic, Plastic and Reconstructive Surgery at Macquarie University, Professor Anand Deva is a global authority on breast implant safety. His groundbreaking research on infection control and systemic health innovation speaks volumes of his contributions to the clinical community.
Dr. Michael Edwards
As a Past President of the American Society for Aesthetic Plastic Surgery, Dr. Michael Edwards emphasizes patient education and ethical surgical practices. His reputation as one of the top plastic surgeons in the U.S. is well-earned through his commitment to advancing reconstructive techniques and mentoring young professionals in the field.
Dr. Caroline Glicksman
Dr. Caroline Glicksman, recognized widely for her leadership in breast surgery, has been a Principal Investigator in numerous major silicone breast implant trials. With degrees in microbiology, sociology, and a law degree in pharmaceutical and medical device law, she advocates for patient safety and innovative clinical outcomes.
Dr. Mark L. Jewell
Serving as Assistant Clinical Professor of Plastic Surgery at Oregon Health Science University, Dr. Mark Jewell has a long-standing reputation as a clinical researcher and speaker on aesthetic surgery. His advisory roles and scholarly contributions continue to influence industry standards significantly.
“It’s important to note that the global recognition of our clinical advisors reflects their leadership in prestigious societies within the field,” added Dr. med. Tobias Grossner, Chief Medical Officer (CMO) of BellaSeno. With a pivotal clinical trial of the company’s resorbable breast implants on the horizon, the insight and expertise from the advisory board will play a crucial role in the company’s clinical strategy moving forward.
About BellaSeno GmbH
Founded in 2015, BellaSeno GmbH is headquartered in Leipzig, Germany, with a subsidiary based in Brisbane, Australia. The company is dedicated to developing novel resorbable soft tissue and bone reconstruction implants using additive manufacturing technology, under ISO 13485 certification. BellaSeno is supported by substantial investments from private sectors and various government bodies, showcasing its innovative approach to health technology.
Contact Information
For more information, contact:
BellaSeno GmbH
Dr. Mohit Chhaya
Email: mohit.chhaya@bellaseno.com
Phone: +49 176 2283 9583
Media Inquiries:
akampion
Dr. Ludger Wess / Ines-Regina Buth
Email: info@akampion.com
Phone: +49 40 88 16 59 64
Phone: +49 30 23 63 27 68
Frequently Asked Questions
What is BellaSeno's primary focus?
BellaSeno focuses on developing resorbable implants for soft tissue and bone reconstruction using advanced 3D printing technologies.
Who are the members of BellaSeno's Clinical Advisory Board?
The advisory board includes leading figures like Dr. William P. Adams, Dr. Patricia McGuire, and Dr. Bob Basu, among others.
What is the significance of the Clinical Advisory Board?
The Clinical Advisory Board will provide expert guidance as BellaSeno prepares to initiate pivotal clinical trials for their innovative breast implants.
When was BellaSeno GmbH founded?
BellaSeno GmbH was founded in 2015 and is based on the BioCity campus in Leipzig, Germany.
How can I contact BellaSeno for more information?
You can reach out to Dr. Mohit Chhaya at mohit.chhaya@bellaseno.com or call +49 176 2283 9583.
